149 related articles for article (PubMed ID: 16419060)
21. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
22. Infrequent p53 gene mutations in medulloblastomas.
Saylors RL; Sidransky D; Friedman HS; Bigner SH; Bigner DD; Vogelstein B; Brodeur GM
Cancer Res; 1991 Sep; 51(17):4721-3. PubMed ID: 1873817
[TBL] [Abstract][Full Text] [Related]
23. The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats.
Barbouti A; Stankiewicz P; Nusbaum C; Cuomo C; Cook A; Höglund M; Johansson B; Hagemeijer A; Park SS; Mitelman F; Lupski JR; Fioretos T
Am J Hum Genet; 2004 Jan; 74(1):1-10. PubMed ID: 14666446
[TBL] [Abstract][Full Text] [Related]
24. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
25. Derivative (22)t(3;22)(q12;p11.1) in desmoplastic medulloblastoma.
Manor E; Bodner L; Kachko P; Kapelushnik J
Cancer Genet Cytogenet; 2010 Jan; 196(2):175-8. PubMed ID: 20082855
[TBL] [Abstract][Full Text] [Related]
26. Translocation and gross deletion breakpoints in human inherited disease and cancer II: Potential involvement of repetitive sequence elements in secondary structure formation between DNA ends.
Chuzhanova N; Abeysinghe SS; Krawczak M; Cooper DN
Hum Mutat; 2003 Sep; 22(3):245-51. PubMed ID: 12938089
[TBL] [Abstract][Full Text] [Related]
27. Expression of GAS7 in childhood CNS tumors.
Ebinger M; Senf L; Wachowski O; Scheurlen W
Pediatr Blood Cancer; 2006 Mar; 46(3):325-8. PubMed ID: 16078223
[TBL] [Abstract][Full Text] [Related]
28. Characterization of chromosome 17 abnormalities in medulloblastomas.
Aldosari N; Rasheed BK; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Acta Neuropathol; 2000 Apr; 99(4):345-51. PubMed ID: 10787031
[TBL] [Abstract][Full Text] [Related]
29. The origin of chromosome imbalances in neuroblastoma.
Stallings RL; Yoon K; Kwek S; Ko D
Cancer Genet Cytogenet; 2007 Jul; 176(1):28-34. PubMed ID: 17574961
[TBL] [Abstract][Full Text] [Related]
30. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
[TBL] [Abstract][Full Text] [Related]
31. Concurrent gain of 17q and the MYC oncogene in a medullomyoblastoma.
Lindberg E; Persson A; Øra I; Mertens F; Englund E; Gisselsson D
Neuropathology; 2007 Dec; 27(6):556-60. PubMed ID: 18021376
[TBL] [Abstract][Full Text] [Related]
32. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.
Van Roy N; Vandesompele J; Berx G; Staes K; Van Gele M; De Smet E; De Paepe A; Laureys G; van der Drift P; Versteeg R; Van Roy F; Speleman F
Genes Chromosomes Cancer; 2002 Oct; 35(2):113-20. PubMed ID: 12203774
[TBL] [Abstract][Full Text] [Related]
33. Genomic amplification of orthodenticle homologue 2 in medulloblastomas.
Boon K; Eberhart CG; Riggins GJ
Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863
[TBL] [Abstract][Full Text] [Related]
34. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.
Łastowska M; Cotterill S; Bown N; Cullinane C; Variend S; Lunec J; Strachan T; Pearson AD; Jackson MS
Genes Chromosomes Cancer; 2002 Aug; 34(4):428-36. PubMed ID: 12112532
[TBL] [Abstract][Full Text] [Related]
35. Copy number variation at the breakpoint region of isochromosome 17q.
Carvalho CM; Lupski JR
Genome Res; 2008 Nov; 18(11):1724-32. PubMed ID: 18714090
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and analysis of breakpoints on ring chromosome 17 in a patient with autism.
Vazna A; Havlovicova M; Sedlacek Z
Gene; 2008 Jan; 407(1-2):186-92. PubMed ID: 17996402
[TBL] [Abstract][Full Text] [Related]
37. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
Yoshimoto M; Bayani J; Nuin PA; Silva NS; Cavalheiro S; Stavale JN; Andrade JA; Zielenska M; Squire JA; de Toledo SR
Cancer Genet Cytogenet; 2006 Oct; 170(1):40-7. PubMed ID: 16965953
[TBL] [Abstract][Full Text] [Related]
38. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
39. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
